YU7396A - New pharmaceutical dosage form with one inhibitor of protone pump and at least one antibacterical composition and process for preparation - Google Patents

New pharmaceutical dosage form with one inhibitor of protone pump and at least one antibacterical composition and process for preparation

Info

Publication number
YU7396A
YU7396A YU7396A YU7396A YU7396A YU 7396 A YU7396 A YU 7396A YU 7396 A YU7396 A YU 7396A YU 7396 A YU7396 A YU 7396A YU 7396 A YU7396 A YU 7396A
Authority
YU
Yugoslavia
Prior art keywords
dosage form
preparation
pharmaceutical dosage
inhibitor
antibacterical
Prior art date
Application number
YU7396A
Other languages
Serbo-Croatian (sh)
Inventor
Helene Depui
Adam Rosinski
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9500422A external-priority patent/SE9500422D0/en
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of YU7396A publication Critical patent/YU7396A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pronalazak se odnosi na jedan oralni farmaceutski dozni oblik koji sadrži jedan inhibitor protonske pumpe i najmanje jedno protivbakterijsko jedinjenje u čvrstoj formulaciji kao i na postupak za njegovu izradu. Čvrsta formulacija je u vidu tablete prevučene enteričkom oblogom, kapsule ili višejediničnog doznog oblika u tabletama. Aktivna je materija omeprazol ili njegovi pojedinačni enantiomeri ili njegova alkalna so, ili lansoprazol, dok je protivbakterijsko jedinjenje amoksicilin i/ili klaritromicin i/ili metronidazol. Najpreporučljiviji je višejedinični dozni oblik. Nova čvrsta formulacija je posebno pogodna kod lečenja poremećaja povezanih sa Helicobacter infekcijama.The invention relates to an oral pharmaceutical dosage form containing one proton pump inhibitor and at least one antibacterial compound in a solid formulation and to a process for its preparation. The solid formulation is in the form of enteric coated tablets, capsules or multi-unit dosage forms in tablets. The active substance is omeprazole or its individual enantiomers or its alkali salt or lansoprazole, while the antibacterial compound is amoxicillin and / or clarithromycin and / or metronidazole. The most preferred is a multi-unit dosage form. The new solid formulation is particularly suitable for the treatment of disorders associated with Helicobacter infections.

YU7396A 1995-02-06 1996-02-06 New pharmaceutical dosage form with one inhibitor of protone pump and at least one antibacterical composition and process for preparation YU7396A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500422A SE9500422D0 (en) 1995-02-06 1995-02-06 New oral pharmaceutical dosage forms

Publications (1)

Publication Number Publication Date
YU7396A true YU7396A (en) 1998-08-14

Family

ID=47598445

Family Applications (1)

Application Number Title Priority Date Filing Date
YU7396A YU7396A (en) 1995-02-06 1996-02-06 New pharmaceutical dosage form with one inhibitor of protone pump and at least one antibacterical composition and process for preparation

Country Status (3)

Country Link
KR (1) KR100399524B1 (en)
TN (1) TNSN96025A1 (en)
YU (1) YU7396A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions

Also Published As

Publication number Publication date
TNSN96025A1 (en) 2005-03-15
KR100399524B1 (en) 2004-04-13

Similar Documents

Publication Publication Date Title
YU70196A (en) Effervescent tablet dosage forms and process for preparation thereof
SE9500422D0 (en) New oral pharmaceutical dosage forms
NO20012222L (en) Pharmaceutical formulation including omeprazole
TR199500825A2 (en) Multi-unit pharmaceutical preparation.
NO20023313D0 (en) Newly substituted benzimidazole dosage forms and methods for using the same
EE04800B1 (en) Oral dosage form for acid unstable active ingredient, unit dosage form, method of preparation and use, and method for oral dosage form
IT1246383B (en) METHOD FOR MASKING THE TASTE OF DRUGS
MX9600857A (en) Multiple unit tableted dosage form i.
IT1245761B (en) PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY.
NO2000010I1 (en) Pharmaceutically acceptable salts of esomeprazole
EE200000096A (en) Pharmaceutical preparation containing the active substance clodronate and siliconized microcrystalline cellulose as excipient
NO20060786L (en) Pharmaceutical preparations with swelling coating
RS50298B (en) Directly compressibile matrix for controlled release of single daily doses of clarithromycin
SE8804628D0 (en) NEW COMPOUNDS
IS3789A7 (en) Method of Preparation of Dosage in Solid Formed Temporary Release of Active Component
NO912414L (en) RELATIONSHIP WITH MAGIC ACID INHIBITING EFFECT AND PROCEDURE FOR ITS MANUFACTURING.
ATE329589T1 (en) MULTIPARTICULAR BISOPROLOL FORMULATION
YU7396A (en) New pharmaceutical dosage form with one inhibitor of protone pump and at least one antibacterical composition and process for preparation
WO2002056867A3 (en) Extended release pharmaceutical compositions containing beta-lactam antibiotics
EE03954B1 (en) Method for the preparation of the carbamazepine sustained release dosage form
GB9420748D0 (en) 1,5 benzodiazepine derivatives
AR028929A1 (en) PROCEDURE TO PREPARE STABLE PHARMACEUTICAL COMPOSITIONS OF THE TYPE COMPRESSED CONTAINING OMEPRAZOL, SODIUM ALGINATE AND A BASIC AMINO ACID AND PHARMACEUTICAL COMPOSITIONS IN TABLETS OBTAINED WITH SUCH PROCEDURE
JO1881B1 (en) Multiple unit tableted dosage from ii